Rhythm Biosciences (RHY.AX) Stock Price

Rhythm Biosciences Price

ASX·CLOSED
0.06
​
Market closed

Over the last 8 years Rhythm Biosciences grew revenue by 3.6% annually, reaching 85,339.00 AUD. For Rhythm Biosciences, the net margin of -6,948.8% is down versus -362.3% a few years ago.

Rhythm Biosciences stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rhythm Biosciences business model & stock analysis

Rhythm Biosciences Ltd develops and commercializes medical diagnostics technologies, focusing on the ColoSTAT blood-based cancer test for early colorectal cancer detection. The test measures five specific biomarkers in blood to identify colorectal cancer tumors in adults aged 40 to 85 at average risk. ColoSTAT is positioned as an alternative screening option for individuals unable or unwilling to use existing screening methods. The company targets domestic and international markets for its diagnostic solutions, with ColoSTAT serving as its primary product for colorectal cancer screening.

Frequently asked questions about Rhythm Biosciences

Converted at the current exchange rate, the Rhythm Biosciences share trades at 0.04 EUR (0.06 AUD).

The Rhythm Biosciences share (RHY.AX) is listed on 2 stock exchanges, including: ASX (RHY.AX), Frankfurt (0RY.F).

The revenue of Rhythm Biosciences is 85,339.00 AUD. This figure is based on current financial data and reflects the company's business performance.

The profit of Rhythm Biosciences is -5.93 M AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Rhythm Biosciences is currently -3.78. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Rhythm Biosciences stock.

The price-to-sales ratio (P/S) of Rhythm Biosciences is currently 262.87. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Rhythm Biosciences stock.

The Eulerpool Quality Score for Rhythm Biosciences is 2/10.

The ISIN of Rhythm Biosciences is AU000000RHY2. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Rhythm Biosciences is A2H8M4. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Rhythm Biosciences is RHY.AX. The ticker symbol is used to trade Rhythm Biosciences shares on the stock exchange.

Fair ValueTerminal
0.05 AUD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Australia
Currency
AUD
Initial public offering
Dec 7, 2017
ISIN
AU000000RHY2
Cusip
Q8137L104
Market capitalization
21.32 M AUDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
5.86
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-152.63 %
Last updated Oct 28, 2026, 6:17 PM

Rhythm Biosciences Peer Group

Rhythm Biosciences Ticker

ASX · RHY.AXFRANKFURT · 0RY.F

Rhythm Biosciences FIGI

RHY:AU · BBG00HZRNTK3RHY:AT · BBG00HZRNTL2RHY:AH · BBG00HZRNTQ7RHYEUR:X2 · BBG00JHWPBY0RHYEUR:XB · BBG00JHWPBZ9RHYEUR:XH · BBG00JHWPC14RHYEUR:XF · BBG00JHWPC32RHYEUR:XE · BBG00JHWPC50RHYEUR:XJ · BBG00JHWPC69RHYEUR:XL · BBG00JHWPC78RHYEUR:XG · BBG00JHWPC87RHYEUR:XO · BBG00JHWPC96